Johnson and Johnson 2014 Annual Report Download - page 78

Summary of Operations and Statistical Data
2004-2014
(Dollars in Millions Except Per Share
Amounts) 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Sales to customers – U.S. $34,782 31,910 29,830 28,908 29,450 30,889 32,309 32,444 29,775 28,377 27,770
Sales to customers – International 39,549 39,402 37,394 36,122 32,137 31,008 31,438 28,651 23,549 22,137 19,578
Total sales 74,331 71,312 67,224 65,030 61,587 61,897 63,747 61,095 53,324 50,514 47,348
Cost of products sold 22,746 22,342 21,658 20,360 18,792 18,447 18,511 17,751 15,057 14,010 13,474
Selling, marketing and administrative expenses 21,954 21,830 20,869 20,969 19,424 19,801 21,490 20,451 17,433 17,211 16,174
Research and development expense 8,494 8,183 7,665 7,548 6,844 6,986 7,577 7,680 7,125 6,462 5,344
In-process research and development 178 580 1,163 – – – 181 807 559 362 18
Interest income (67) (74) (64) (91) (107) (90) (361) (452) (829) (487) (195)
Interest expense, net of portion capitalized 533 482 532 571 455 451 435 296 63 54 187
Other (income) expense, net (70) 2,498 1,626 2,743 (768) (526) (1,015) 534 (671) (214) 15
Restructuring – – – 569 – 1,073 – 745 – – –
53,768 55,841 53,449 52,669 44,640 46,142 46,818 47,812 38,737 37,398 35,017
Earnings before provision for taxes on income $20,563 15,471 13,775 12,361 16,947 15,755 16,929 13,283 14,587 13,116 12,331
Provision for taxes on income 4,240 1,640 3,261 2,689 3,613 3,489 3,980 2,707 3,534 3,056 4,151
Net earnings 16,323 13,831 10,514 9,672 13,334 12,266 12,949 10,576 11,053 10,060 8,180
Add: Net loss attributable to noncontrolling
interest – –339 – –––––––
Net earnings attributable to Johnson &
Johnson 16,323 13,831 10,853 9,672 13,334 12,266 12,949 10,576 11,053 10,060 8,180
Percent of sales to customers 22.0% 19.4 16.1 14.9 21.7 19.8 20.3 17.3 20.7 19.9 17.3
Diluted net earnings per share of common
stock(1) $5.70 4.81 3.86 3.49 4.78 4.40 4.57 3.63 3.73 3.35 2.74
Percent return on average shareholders’ equity 22.7% 19.9 17.8 17.0 24.9 26.4 30.2 25.6 28.3 28.2 27.3
Percent increase (decrease) over previous
year:
Sales to customers 4.2% 6.1 3.4 5.6 (0.5) (2.9) 4.3 14.6 5.6 6.7 13.1
Diluted net earnings per share 18.5% 24.6 10.6 (27.0) 8.6 (3.7) 25.9 (2.7) 11.3 22.3 19.7
Supplementary balance sheet data:
Property, plant and equipment, net 16,126 16,710 16,097 14,739 14,553 14,759 14,365 14,185 13,044 10,830 10,436
Additions to property, plant and equipment 3,714 3,595 2,934 2,893 2,384 2,365 3,066 2,942 2,666 2,632 2,175
Total assets 131,119 132,683 121,347 113,644 102,908 94,682 84,912 80,954 70,556 58,864 54,039
Long-term debt 15,122 13,328 11,489 12,969 9,156 8,223 8,120 7,074 2,014 2,017 2,565
Operating cash flow 18,471 17,414 15,396 14,298 16,385 16,571 14,972 15,022 14,248 11,799 11,089
Common stock information
Dividends paid per share $2.76 2.59 2.40 2.25 2.11 1.93 1.795 1.62 1.455 1.275 1.095
Shareholders’ equity per share 25.06 26.25 23.33 20.95 20.66 18.37 15.35 15.25 13.59 13.01 10.95
Market price per share (year-end close) $105.06 92.35 69.48 65.58 61.85 64.41 58.56 67.38 66.02 60.10 63.42
Average shares outstanding (millions)
– basic 2,815.2 2,809.2 2,753.3 2,736.0 2,751.4 2,759.5 2,802.5 2,882.9 2,936.4 2,973.9 2,968.4
– diluted 2,863.9 2,877.0 2,812.6 2,775.3 2,788.8 2,789.1 2,835.6 2,910.7 2,961.0 3,002.8 2,992.7
Employees (thousands) 126.5 128.1 127.6 117.9 114.0 115.5 118.7 119.2 122.2 115.6 109.9
(1) Attributable to Johnson & Johnson.
68 •Johnson & Johnson 2014 Annual Report